Health and Healthcare

Dendreon Taps Financing Sooner Than Expected

Shares of Dendreon (DNDN) are trading down some 7% pre-market after the company announced that it was going to offer $75 million in convertible senior subordinated notes that are due in 2014.  The offering is being made under Rule 144A to qualified institutional buyers, so the securities will not be required to be registered until a reseale period.

The terms are still T.B.A. and are being negotiated, plus their is a $25 million overallotment option.

The Company intends to use the net proceeds of this offering to finance its activities relating to the potential commercialization of Provenge®, expand its manufacturing facilities for the commercial production of PROVENGE, fund ongoing and new clinical trials for PROVENGE and its other product candidates, support research and preclinical development activities for its other potential product candidates, and for general corporate purposes, including working capital.

This financial offering seems far sooner than the company had previously focused on.  It never did give a formal date on "when it would raise cash" under its existing shelf filing with the SEC, but the body language signal out of the company would have led you to believe this was being set for much later in 2007.

Jon C. Ogg
June 4, 2007

Jon Oggcan be reached at [email protected]; he does not own securities in the companies he covers.

Is Your Money Earning the Best Possible Rate? (Sponsor)

Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.

However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.

There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.